Visceral Pain Market

Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
Visceral Pain Market aims to provide a comprehensive presentation of the global market for Visceral Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Visceral Pain. Visceral Pain Market contains market size and forecasts of Visceral Pain in global, including the following market information:
Global Visceral Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Visceral Pain market was valued at US$ 1018 million in 2022 and is projected to reach US$ 1298.8 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
We surveyed the Visceral Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Visceral Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Visceral Pain Market Segment Percentages, by Type, 2022 (%)
Analgesics
Pain Modifiers
Global Visceral Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Visceral Pain Market Segment Percentages, by Application, 2022 (%)
Interstitial Cystitis
Crohn?s
Irritable Bowel
Chronic Prostatitis
Global Visceral Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Visceral Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Visceral Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Visceral Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Visceral Pain, market overview.
Chapter 2: Global Visceral Pain market size in revenue.
Chapter 3: Detailed analysis of Visceral Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Visceral Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.